Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for NAD+ binding (biogroup)
Most Correlated Studies
- L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
- L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
- Lungs of smokers with and without COPD - miRNA expression
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- L1000 CMAP - Skeletal muscle SKL.C cells treated with small molecule perturbagens
Most Relevant Literature
- Characterization of glycine substitution mutations within the putative NAD+-binding site of Bacillus…
- Structural signatures of enzyme binding pockets from order-independent surface alignment: a study of…
- Heterogeneity of active sites in recombinant betaine aldehyde dehydrogenase is modulated by potassiu…
- Novel inhibitors of glyceraldehyde-3-phosphate dehydrogenase: covalent modification of NAD-binding s…
- Structure and electron transfer pathways of an electron-bifurcating NiFe-hydrogenase.
Most Relevant Clinical Trials
- Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
- Protection From Acute Kidney Injury (AKI) With Basis™ Treatment
- Increased Adsorption Membranes During Cardiopulmonary Bypass
- The Correlation Between Lung Cancer Susceptibility, Drug Response and Genetic Polymorphism
- IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer
